FAQS

We are a pioneering healthcare company at the forefront of innovation in epigenetics, early cancer detection, and personalized health solutions. Our cutting-edge research and products aim to revolutionize healthcare by leveraging DNA methylation analysis and advanced technologies.
Your results indicate your biological age based on a variety of factors. This age may be different from your numerical age.
  • Measures of frailty
  • Graying of hair
  • Aging of skin
  • Levels of different kinds of white blood cells

Epigenetics holds the key to your overall health and well-being. Aberrant epigenetic programming of our DNA could lead to different kinds of diseases from cancer to Alzheimer’s disease and diabetes.

​Even better, these findings will lead to new ideas on how to prevent and treat or cure cancer, Alzheimer’s disease, diabetes, addictions, and more…even  before they occur.

​Right now, HKG Epitherapeutics is a pioneer in developing the most advanced medical innovations for the early detection and prevention of diseases that affect huge populations of people worldwide using DNA methylation markers. Our visions are already happening.

EpiAging tests make sense only within a dynamic lifelong lifestyle, environmental, and health management system.

A personalized evaluation including intervention will be generated based on the health and lifestyle information you provided.

Updates on your health and lifestyle parameters periodically to activate the lifelong personalized analysis report

  • Continuously analyze Epiaging test results, general health parameters, personal interventions, and the outcomes of multiple users using state-of-the-art machine learning algorithms.
  • Personalized analysis with some possible routes for improvement​.
  • Coevolving of your well-being and our “Epiaging” learning environment.

We perform three independent tests on your saliva using next-generation sequencing technology. We provide you with an average of the three tests and the technical accuracy of the score. The closer the technical accuracy is to 100%, the closer the test results are to each other.

Founded in 2016, HKG Epitherapeutics specializes in epigenetic research for early disease detection and promoting healthy aging, focusing on innovative DNA Methylation analysis.
Our offerings include consumer-friendly epigenetic tests like epiAge, epiSmoke, and MetaGen, alongside advanced liquid biopsy products and the MGMT methylation test for personalized cancer treatment.
Epigenetic changes, especially in DNA methylation patterns, are crucial in identifying cancer early and guiding personalized treatment strategies based on specific genetic profiles.
Our unique approach combines advanced epigenetic profiling and computational methods to develop high-throughput assays for early disease detection, emphasizing personalized healthcare management.
Healthcare professionals looking to collaborate can contact us at info@hkgepitherapeutics.com for opportunities in joint research, clinical trials, and partnerships.
Our tests and services are available for direct consumer purchase on our website. Researchers and healthcare providers can access experimental stage products. For more details, contact info@hkgepitherapeutics.com.
Our primary lab is in the Hong Kong Science Park, with a subsidiary in Montreal, Canada for bioinformatics, a lab in Shenzhen, China, and plans to open a new office in New York soon.
Scroll to Top